Cite
Kirschner, K. M., & Baltensperger, K. (2003). Erythropoietin Promotes Resistance Against the Abl Tyrosine Kinase Inhibitor Imatinib (STI571) in K562 Human Leukemia Cells11Swiss National Science Foundation grant 31-059124 and Swiss Cancer League grant SKL 778-2-1999. Note: Current address of Dr. Karin M. Kirschner is at Johannes-Müller Institut fu̇r Physiologie, Charité-Universitätsmedizin Berlin, Campus Charité-Mitte, Tucholskystrasse 2, 10117 Berlin, Germany. Molecular cancer research, 1(13), 970-980.
Kirschner, Karin M., and Kurt Baltensperger. "Erythropoietin Promotes Resistance Against the Abl Tyrosine Kinase Inhibitor Imatinib (STI571) in K562 Human Leukemia Cells11Swiss National Science Foundation grant 31-059124 and Swiss Cancer League grant SKL 778-2-1999. Note: Current address of Dr. Karin M. Kirschner is at Johannes-Müller Institut fu̇r Physiologie, Charité-Universitätsmedizin Berlin, Campus Charité-Mitte, Tucholskystrasse 2, 10117 Berlin, Germany." Molecular cancer research 1.13 (2003): 970-980.
Copy
Download .nbib
